News | December 15, 2025
Indoco receives EIR from the USFDA for its API manufacturing facility at Patalganga
Indoco received the Establishment Inspection Report from the USFDA for its API manufacturing facility
Indoco received the Establishment Inspection Report from the USFDA for its API manufacturing facility
_Logo_256_384.png){kind=logo}
The Vital Shape panels provide tiered assessments to detect obesity-related risks early
Renalyx will continue operating as an independent unit within the group
Partnership combines MilliporeSigma’s chemistry and organoid expertise with Promega’s assay technologies
Panacea Biotec receives Rs. 315 crore LoA from UNICEF
Clinical evidence has consistently highlighted lacosamide’s efficacy and safety.
The inspection concluded with zero form 483 observations
The company has improved access to quality healthcare for seniors across both urban and rural areas
The company’s virgin PET chips plant in Egypt, commissioned in Q4 FY25, achieved 74.8 per cent capacity utilization in its first full quarter. In India, the Panipat facility operated at 96.6 per cent utilization
Rivaroxaban is used to treat venous thromboembolism
Subscribe To Our Newsletter & Stay Updated
